STAT3 and cardiac hypertrophy: Collectively, this study has unveiled a novel molecular mechanism involving the interaction between ECSIT‐X4 and STAT3 within mitochondria, which serves to mitigate energy deficits in hypertrophic cardiomyocytes and pathological cardiac hypertrophy.